Skip to content
12 May, 2022
Latest News
Bill Gates Says He Has COVID-19, Experiencing Mild Symptoms
WHO Studies Whether COVID-19 Has Role in Child Hepatitis Mystery
Shanghai Tightens Lockdown Despite Falling COVID Cases
  • Home
  • Contact
  • Submit News
  • Sitemap
lesothowire.com
  • Home
  • General
  • Industry
  • Judicial
  • Medicine
  • Arts
  • National
  • Literacy
  • Athletic
  • Press Releases
  • Home
  • Medicine

Category: Medicine

WHO says over 1 mln African children vaccinated against malaria

April 22, 2022 lwadmin

NAIROBI, More than one million children in Kenya, Ghana and Malawi have received one or extra doses of the world’s first malaria vaccine as efforts to eradicate the disease in the continent gathers steam, the World Health Organization (WHO) said …

Medical, Medicine

On World Health Day, US Lacks Funding for Global COVID Response

April 7, 2022 lwadmin

Without a single dollar of the $5 billion it requested for its global COVID-19 response approved, the Biden administration’s key program to help vaccinate the world is in danger of grinding to a halt.

Even as the administration marked World …

Medical, Medicine

Lesotho Remote Monitoring Update, February 2022

March 1, 2022 lwadmin

Key Messages

• The peak of the lean season is ongoing, and food stocks from own production are largely depleted among poor households, increasing their reliance on markets for food using income earned from casual agricultural and non-agricultural labor opportunities. …

Medical, Medicine

COVID Prompts Calls for More Investment in Africa’s Health Care Systems

February 23, 2022 lwadmin

Experts are calling for increased investment in Africa’s health care infrastructure to support data collection, research and development related to the COVID-19 pandemic and its subsequent impact on African economies.

In a recent discussion on VOA’s Straight Talk Africa program …

Medicine

African Health Authorities Meet in Nigeria, Discuss Vaccination Goals

February 23, 2022 lwadmin

African health authorities are calling for better coordination to ensure COVID-19 vaccines are distributed quickly to all African nations.

Vaccine supplies have surpassed demand for the first time since the pandemic began two years ago. But health officials at a …

Medical, Medicine

FDA Delayed Pfizer Shot for Children Because it Didn’t Work Well Against Omicron

February 18, 2022 lwadmin

The Wall Street Journal Friday, citing sources close to the decision, reported the U.S. Food and Drug Administration (FDA) last week delayed its review of the Pfizer-BioNTech COVID-19 vaccine for under-5-year-olds because initial testing showed its two-dose series was not …

Medical, Medicine

IAE: Russia Undermining European Gas Supply Amid Ukraine Standoff

January 12, 2022 lwadmin

Russia is contributing to an undersupply of natural gas to Europe, the head of the International Energy Agency (IEA) Fatih Birol said on Wednesday, noting it comes amid a standoff between Moscow and the West over Ukraine.

The Paris-based IEA, …

Medical, Medicine

T?KA Supports Lesotho’s Fight against COVID-19

January 7, 2022 lwadmin

Turkish Cooperation and Coordination Agency (TIKA) provided protective equipment and hygiene products to the Ministry of Foreign Affairs and International Relations of the Kingdom of Lesotho in order to fight against COVID-19.

As part of the project, personal hygiene products …

Medical, Medicine

UK to Lift COVID Travel Ban on 11 African Countries

December 14, 2021 lwadmin

Britain will end a ban on visitors from 11 African countries aimed at combatting COVID-19, the government said Tuesday, despite an alarming spread of the omicron variant of the coronavirus.

After the variant was first detected in southern Africa and …

Medical, Medicine

Posts navigation

1 2 … 33 Next

Search

Calender

May 2022
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
« Apr    

Categories

  • General
  • Industry
  • Judicial
  • Medicine
  • Arts
  • National
  • Literacy
  • Athletic
  • Press Releases

Advertisement

Latest News

Bill Gates Says He Has COVID-19, Experiencing Mild Symptoms

  • 10 May 2022

Microsoft co-founder Bill Gates said Tuesday he has tested positive for COVID-19 and is experiencing mild symptoms.Via Twitter, the billionaire...

WHO Studies Whether COVID-19 Has Role in Child Hepatitis Mystery

  • 10 May 2022

The WHO said Tuesday that 348 probable cases of hepatitis of unknown origin had been identified, as studies into the...

Shanghai Tightens Lockdown Despite Falling COVID Cases

  • 9 May 2022

Authorities in Shanghai have again tightened anti-virus restrictions, just as the city was emerging from a month of strict lockdown...

Rare Cases of COVID Returning Prompt Questions About Pfizer PillAs more doctors prescribe Pfizer’s powerful COVID-19 pill, new questions are emerging about its performance, including why a small number of patients appear to relapse after taking the drug. Paxlovid has become the go-to option against COVID-19 because of its at-home convenience and impressive results in heading off severe disease. The U.S. government has spent more than $10 billion to purchase enough pills to treat 20 million people. But experts say there is still much to be learned about the drug, which was authorized in December for adults at high risk of severe COVID-19 based on a study in which 1,000 adults received the medication. Why do some patients seem to relapse? Doctors have started reporting rare cases of patients whose symptoms return several days after completing Paxlovid’s five-day regimen of pills. That has prompted questions about whether those patients are still contagious and should receive a second course of Paxlovid. Last week, the Food and Drug Administration weighed in. It advised against a second round because there’s little risk of severe disease or hospitalization among patients who relapse. Dr. Michael Charness reported last month on a 71-year-old vaccinated patient who saw his symptoms subside but then return, along with a spike in virus levels nine days into his illness. Charness says Paxlovid remains a highly effective drug, but he wonders if it might be less potent against the current omicron variant. The $500 drug treatment was tested and approved based on its performance against the delta version of the coronavirus. “The ability to clear the virus after it’s suppressed may be different from omicron to delta, especially for vaccinated people,” said Charness, who works for Boston’s VA health system. Could some people just be susceptible to a relapse? Both the FDA and Pfizer point out that 1% to 2% of people in Pfizer’s original study saw their virus levels rebound after 10 days. The rate was about the same among people taking the drug or dummy pills, “so it is unclear at this point that this is related to drug treatment,” the FDA stated. Some experts point to another possibility: The Paxlovid dose isn’t strong enough to fully suppress the virus. Andy Pekosz of Johns Hopkins University worries that could spur mutations that are resistant to the drug. “We should really make sure we’re dosing Paxlovid appropriately because I would hate to lose it right now,” said Pekosz, a virologist. “This is one of the essential tools we have to help us turn the corner on the pandemic.” How well does Paxlovid work in vaccinated people? Pfizer tested Paxlovid in the highest-risk patients: unvaccinated adults with no prior COVID-19 infection and other health problems, such as heart disease and diabetes. The drug reduced their risk of hospitalization and death from 7% to 1%. But that doesn’t reflect the vast majority of Americans today, where 89% of adults have had at least one shot. And roughly 60% of Americans have been infected with the virus at some point. “That’s the population I care about in 2022 because that’s who we’re seeing – vaccinated people with COVID – so do they benefit?” asked Dr. David Boulware, a University of Minnesota researcher and physician. There’s no clear answer yet for vaccinated Americans, who already have a hospitalization rate far below 1%. That may come from a large ongoing Pfizer study that includes high-risk vaccinated people. No results have been published; the study is expected to wrap up in the fall. Pfizer said last year that initial results showed Paxlovid failed to meet the study’s goals of significantly resolving symptoms and reducing hospitalizations. It recently stopped enrolling anyone who’s received a vaccination or booster in the past year, a change Boulware says suggests those patients aren’t benefitting. At a minimum, the preliminary data should be released to federal officials, Boulware said. “If the U.S. government is spending billions of dollars on this medicine, what’s the obligation to release that data so that they can formulate a good policy?” Can Paxlovid be used to help prevent COVID-19 infection? Pfizer recently reported that proactively giving Paxlovid to family members of people infected with COVID-19 didn’t significantly reduce their chances of catching it. But that’s not the end of the story. Pfizer is studying several other potential benefits of early use, including whether Paxlovid reduces the length and severity of COVID-19 among households. “It’s a high bar to protect against infection, but I’d love to see data on how Paxlovid did against severe disease because it may be more effective there,” Pekosz said. Source: Voice of America

  • 9 May 2022

As more doctors prescribe Pfizer's powerful COVID-19 pill, new questions are emerging about its performance, including why a small number...

As Beijing COVID Outbreak Proves Stubborn, Mass Tests Becoming Routine

  • 8 May 2022

Millions of Beijing residents queued up for another round of COVID-19 tests Sunday as China's capital seeks to trace and...

US Workers Grapple With New Stresses as They Return to Office

  • 8 May 2022

Last summer, Julio Carmona started the process of weaning himself off a fully remote work schedule by showing up to...

Pages

  • Home
  • Contact
  • Submit News
  • Sitemap

Latest News

Bill Gates Says He Has COVID-19, Experiencing Mild Symptoms

May 10, 2022

WHO Studies Whether COVID-19 Has Role in Child Hepatitis Mystery

May 10, 2022

Search

Archive

Copyright © 2021 All rights reserved.
Magazine Plus by WEN Themes